ArticlePsychopharmacology2014
Rapid antidepressant effects and abuse liability of ketamine.
Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Effects of subanesthetic ketamine and (2R,6R) hydroxynorketamine on working memory and synaptic transmission in the nucleus reuniens in mice.Neuropharmacology · 2022Article
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.Molecular psychiatry · 2021Article
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.Translational psychiatry · 2019Review
- Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.Psychiatry and clinical neurosciences · 2019Review
- Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats.Physiology & behavior · 2019Article
- Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.Translational psychiatry · 2017Article
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.Scientific reports · 2017Article
- Reduction of dopamine DEuropean archives of psychiatry and clinical neuroscience · 2017Article
- Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.European archives of psychiatry and clinical neuroscience · 2017Article
- Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015.PloS one · 2017Article
- Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.Psychopharmacology · 2016Article
- Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model.Translational psychiatry · 2016Article
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.Current neuropharmacology · 2016Review
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.Psychopharmacology · 2015Article
- BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.Translational psychiatry · 2015Article
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.Translational psychiatry · 2015Article
- Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2015Article
- Inflammatory biomarkers as differential predictors of antidepressant response.International journal of molecular sciences · 2015Review
- Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015Review
- Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.Psychopharmacology · 2014Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24668037What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.